Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1998
03/31/1998US5734022 Antibodies to a novel mammalian protein associated with uncontrolled cell division
03/31/1998US5734021 Having an amino acid sequence as set forth as seq id #2; genetic engineering
03/31/1998US5734019 Hepatitis C virus antigen polypeptide, production method therefor, and antibody detection method
03/31/1998US5734016 Genetic engineering
03/31/1998US5734015 Antibiotics
03/31/1998US5734014 Polypeptide
03/31/1998US5734012 Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity
03/31/1998US5733879 Peptides and proteins, process for their preparation and their use as cholesterol acceptors
03/31/1998US5733878 Morphogen-induced periodontal tissue regeneration
03/31/1998US5733877 Pharmaceutical composition containing biologically active peptide or protein
03/31/1998US5733876 Method of inhibiting angiogenesis
03/31/1998US5733874 Stable dry powders
03/31/1998US5733873 Polyoxamers or polyoxyethylene sorbitan fatty acid esters with sodium chloride, calcium chloride, histidine or sugars
03/31/1998US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
03/31/1998US5733790 CRF binding protein antibodies and assays using same
03/31/1998US5733780 Construction of Pasteurella haemolytica vaccines
03/31/1998US5733778 Vaccines, medical diagnosis
03/31/1998US5733772 Cloning and expression of Plasmodium falciparum transmission blocking target antigen, Pfs230
03/31/1998US5733771 cDNAs encoding minor ampullate spider silk proteins
03/31/1998US5733768 Amyloid precursor protein protease
03/31/1998US5733765 A polypeptide producing a heteropolysaccharide
03/31/1998US5733761 Gene therapy
03/31/1998US5733760 Salmonella vectors encoding truncated pag fusion protein, method of making, and uses thereof
03/31/1998US5733748 Isolated polynucleotide; cancer diagnosis
03/31/1998US5733745 Pure genetic engineered protein
03/31/1998US5733740 Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
03/31/1998US5733730 Telomere repeat binding factor and diagnostic and therapeutic use thereof
03/31/1998US5733727 Myocardial grafts and cellular compositions
03/31/1998US5733556 Newcastle disease virus combination vaccine
03/31/1998US5733554 Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease
03/31/1998US5733553 Nucleotide sequence
03/31/1998US5733549 Peptides including amino acid sequences selected from lipoprotein (a) and apolipoprotein (a), antibodies recognizing these amino acid sequences, and methods of determination using these antibodies
03/31/1998US5733548 Stimulating t-cell response
03/31/1998US5733547 Treatment of autoimmune arthritis by oral administration of type I or type III collagen
03/31/1998US5733546 Immunochemical detection of in vivo advanced glycosylation endproducts
03/31/1998US5733543 Genetic engineering; delaying acquired immune deficiency syndrome (aids) onset
03/31/1998US5733541 Hematopoietic cells: compositions and methods
03/31/1998US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
03/31/1998US5733538 Surface-modifying copolymers having cell adhesion properties
03/31/1998CA2134889C Calcium channel blocking polypeptides from filistata hibernalis
03/31/1998CA2040441C Fusion proteins
03/31/1998CA1339793C Cyclic analogs of atrial natriuretic peptides
03/31/1998CA1339792C Purification of hepatitis proteins
03/31/1998CA1339791C Human nerve growth factor
03/31/1998CA1339782C Fluorescent conjugates and biological diagnostic assay
03/26/1998WO1998012563A1 Method to detect dirofilaria immitis infection
03/26/1998WO1998012562A1 Adhesins from heliobacter pylori and their diagnostic and therapeutic uses
03/26/1998WO1998012558A1 Methods for in vitro determination of erythropoietin bioactivity
03/26/1998WO1998012347A1 Rh blood group antigen compositions and methods of use
03/26/1998WO1998012344A1 Human tumor necrosis factor receptor-like genes
03/26/1998WO1998012339A2 Viral vectors and their uses
03/26/1998WO1998012335A1 Nematode-resistant gene
03/26/1998WO1998012333A1 Immunogenic peptides of foot-and-mouth disease viruses
03/26/1998WO1998012332A1 Compositions and methods for treating intracellular diseases
03/26/1998WO1998012331A1 Novel polypeptide originating in hemophilus paragallinarum and process for producing the same
03/26/1998WO1998012330A1 Mammalian cytokine, related reagents
03/26/1998WO1998012328A2 Human bad polypeptides, encoding nucleic acids and methods of use
03/26/1998WO1998012327A2 Compositions and methods comprising bard1 and other brca1 binding proteins
03/26/1998WO1998012326A1 Hedgehog interacting proteins and uses related thereto
03/26/1998WO1998012325A1 Human gtp binding protein gamma-3
03/26/1998WO1998012324A1 Monocyte chemotactic protein 5 (mcp-5) molecules and uses therefor
03/26/1998WO1998012323A1 Nucleic acid encoding congenital heart disease protein and products related thereto
03/26/1998WO1998012322A1 Bone morphogenetic protein-16 (bmp-16) compositions
03/26/1998WO1998012321A1 Recombinant plant cells expressing heterochromatin 1 (hp1) of drosophila melanogaster
03/26/1998WO1998012320A1 Nucleic acid construct coding for a protein complex from a stat protein and a nuclear receptor and its use
03/26/1998WO1998012319A1 Broad spectrum therapeutic peptide
03/26/1998WO1998012318A1 Thrombin inhibitor
03/26/1998WO1998012317A1 Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents
03/26/1998WO1998012309A2 Method of cell surface activation and inhibition
03/26/1998WO1998012308A1 Soluble polypeptides with activity of the ns3 serine protease of hepatitis c virus, and process for their preparation and isolation
03/26/1998WO1998012306A1 Hematopoietic stem cells and methods for generating such cells
03/26/1998WO1998012305A1 A method of stable integration of dna into neurons
03/26/1998WO1998012302A1 Weight control pathway genes and uses therefor
03/26/1998WO1998012274A1 Methods and devices for preparing protein concentrates
03/26/1998WO1998012226A1 Methods of ameliorating cancer and of inhibiting angiogenesis by using fibronectin
03/26/1998WO1998012225A2 Process for producing a plasma protein-containing medicament
03/26/1998WO1998012224A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/26/1998WO1998012223A1 Novel human interferon-inducible protein
03/26/1998WO1998012222A1 Casein and process for the preparation thereof
03/26/1998WO1998012221A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
03/26/1998WO1998012220A2 Novel tumor proteins
03/26/1998WO1998012212A1 Nucleopeptide complexes, cosmetic and pharmaceutical compositions containing them and their uses
03/26/1998WO1998012208A1 Heat shock protein complexes
03/26/1998WO1998012207A1 High level expression of proteins
03/26/1998WO1998012205A1 Ivi-2, ivi-3 and ivi-4 loci of enterococcus faecalis polynucleotide, polypeptides and method of use therefor
03/26/1998WO1998012204A1 Human b-cell translocation genes-2 and 3
03/26/1998WO1998011925A1 Process of preparation of an autologous fibrin glue
03/26/1998WO1998011917A1 Hiv-1 therapy with il-2 and anti-tnf antibody
03/26/1998WO1998011916A1 Viral defective interfering particles and uses thereof
03/26/1998WO1998011915A1 Strain selection of pneumococcal surface proteins
03/26/1998WO1998011914A1 Targeting antigens to the mhc class i processing pathway with anthrax toxin fusion protein
03/26/1998WO1998011909A1 Use of proteins as agents against autoimmune diseases
03/26/1998WO1998011907A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
03/26/1998WO1998011779A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998WO1998007830A3 COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
03/26/1998WO1998006827A3 Method for immortalizing cells
03/26/1998WO1998004589A3 Production of recombinant plasma gelsolin containing a disulfide bond
03/26/1998WO1998003655A3 Gene expression regulatory dna, expression cassette, expression vector and transgenic plant
03/26/1998WO1998003538A3 Signal-regulated, cleavage-mediated toxins
03/26/1998WO1998000695A3 Tat-sf: cofactor for stimulation of transcriptional elongation by hiv-1 tat